SCHEDULE 13G: Intracoastal Capital Group Discloses 4.99% Passive Stake in 60 Degrees Pharmaceuticals

A group comprising Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC has disclosed a passive beneficial ownership of 4.99% in 60 Degrees Pharmaceuticals, Inc. common stock.

Summary

• Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (collectively, the "Reporting Persons") have filed a Schedule 13G, indicating beneficial ownership in 60 Degrees Pharmaceuticals, Inc.
• As of February 3, 2025, the Reporting Persons collectively beneficially own 284,550 shares of 60 Degrees Pharmaceuticals, Inc. common stock.
• This ownership represents approximately 4.99% of the company's outstanding common stock.
• The shares are primarily issuable upon the exercise of Intracoastal Warrant 1.
• The beneficial ownership percentage is capped at 4.99% due to "blocker provisions" in the warrants, preventing the holder from exceeding this threshold.
• The Reporting Persons state that the securities were not acquired for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While it's a passive stake, the fact that an investment group has committed capital via a Securities Purchase Agreement and holds warrants suggests a degree of confidence in the company. The blocker provision is a minor limiting factor but doesn't negate the investment itself.

Positives

• A notable investment group, Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has taken a significant stake in 60 Degrees Pharmaceuticals, Inc., potentially signaling confidence in the company.
• The investment stems from a Securities Purchase Agreement (SPA), indicating a recent capital infusion into the company.

Negatives

• The presence of a 4.99% blocker provision in the warrants limits the ability of the Reporting Persons to increase their beneficial ownership beyond this threshold, potentially restricting future larger investments or influence.

Risks

• The blocker provisions in the warrants (Intracoastal Warrant 1, 2, 3, and 4) prevent the Reporting Persons from exercising their full warrant entitlements if it would result in beneficial ownership exceeding 4.99% of the common stock, limiting their potential upside from warrant exercise.
• The beneficial ownership is primarily through warrants, which means the actual shares are not yet held and require exercise, subject to the blocker provisions.

Future Outlook

This filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance from the company or the reporting persons regarding future operations or financial performance. It indicates a passive investment stance by the reporting group.

Industry Context

This filing is a standard disclosure of a passive investment stake in a publicly traded company within the pharmaceutical sector. It does not provide broader industry trends but highlights an investor's interest in 60 Degrees Pharmaceuticals, Inc.

Stakeholder Impact

• Shareholders: The disclosure of a new significant investor group may influence market perception and potentially share price.
• Company Management: Awareness of a new significant, albeit passive, shareholder group.

Next Steps

• The Reporting Persons will file amendments to this Schedule 13G if there are material changes to their beneficial ownership or investment intent.

Key Dates

Keywords

60 Degrees Pharmaceuticals, Intracoastal Capital, Mitchell P. Kopin, Daniel B. Asher, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, SEC Filing, Investment, Pharmaceuticals